IP Verse

Il-15 And Il-15Raplha Sushi Domain Based Modulokines - EP3030575

The patent EP3030575 was granted to Assistance Publique Hpitaux DE Paris on Jul 11, 2018. The application was originally filed on Aug 8, 2014 under application number EP14761280A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3030575

ASSISTANCE PUBLIQUE HPITAUX DE PARIS
Application Number
EP14761280A
Filing Date
Aug 8, 2014
Status
Opposition Rejected
Apr 2, 2022
Grant Date
Jul 11, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFApr 10, 2019HGFADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2012175222
OPPOSITIONUS2012177595
OPPOSITIONWO2007046006
OPPOSITIONWO2008143794
OPPOSITIONWO2009002562
OPPOSITIONWO2011020047
OPPOSITIONWO2012040323
OPPOSITIONWO2012175222

Non-Patent Literature (NPL) Citations (4) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- STONE et al., "Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor", Biotechnol Proq, (20121018), vol. 28, no. 6, pages 1588 - 1597, XP055134190
OPPOSITION- HAN et al., "IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization", Cvtokine., (20111022), vol. 56, no. 3, pages 804 - 10, XP028115119
OPPOSITION- KERMER et al., "An antibody fusion protein for cancer immunotherapy mimicking IL-15 trans-presentation at the tumor site", Mol Cancer Ther., (20120406), vol. 11, no. 6, pages 1279 - 1288, XP002683666
OPPOSITION- KERMER et al., "Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy", Mol Cancer Ther., (20131106), vol. 13, no. 1, pages 112 - 121, XP055200723

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents